ANRO — Alto Neuroscience, Inc. stock price, charts and financials

QT92Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (NYSE: ANRO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
30.27
-0.71-2.29%
OverviewShort InterestFilings
ANROQT92Alto Neuroscience, Inc.·NYSE
30.27-2.29%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 27, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 202610-QQuarterly report
Aug 12, 20268-KCurrent report
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 20, 2026SC 13GBeneficial ownership statement (passive)
Jul 14, 2026424B5Prospectus
Jul 14, 20268-KCurrent report
Jul 13, 20268-KCurrent report
May 29, 20263Initial statement of beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 28, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 13, 202610-QQuarterly report
#1 / 25 of 187
Page
▼
/ 8